Does Treatment of Sleep-Disordered Breathing Improve Functional Outcomes in SCI

CompletedNot a drug-phase studyMS (type not specified)NCT02830074

What it found

Results posted, not judged

Results are posted in the registry, but without a statistical test of the main measure. See the numbers below.

What was tested

Treatment tested

  • Best practices PAP + patient Education +ongoing Support and Training

Compared with

  • Sleep Education

Results by group

PAP Adherence

90 days

GroupValueIntervalNumber analysed
The BEST Program22.03 nights24.74 (Standard Deviation)32
Sleep Education and Standard Sleep-disordered Breathing Treatment18.54 nights24.67 (Standard Deviation)31

The BEST Program

22.03

Sleep Education and Standard Sleep-disordered Breathing Treatment

18.54

Subjective Sleep Quality Was Measured by The Pittsburgh Sleep Quality Index (PSQI)

90 days

GroupValueIntervalNumber analysed
The BEST Program6.96 units on a scale4.12 (Standard Deviation)30
Sleep Education and Standard Sleep-disordered Breathing Treatment9.1 units on a scale4.97 (Standard Deviation)30

The BEST Program

6.96

Sleep Education and Standard Sleep-disordered Breathing Treatment

9.1

Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.

Safety

GroupParticipants at riskSerious adverse eventsDeaths
The BEST Program320 (0.0%)0
Sleep Education and Standard SDB Treatment310 (0.0%)0

As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.

What it measured

Main measures

  • PAP Adherence

    90 days

    Quality of life (reported by participants)
  • Subjective Sleep Quality Was Measured by The Pittsburgh Sleep Quality Index (PSQI)

    90 days

    Mood and sleep

Other measures (6)

  • Quality of Life Was Measured by WHO-QOL BREF Questionnaire

    90 days

    Walking and mobilityMood and sleepQuality of life (reported by participants)
  • Respiratory Function: Spirometry and Respiratory Muscle Force

    90 days

    Physical functionMood and sleep
  • Functional Status Was Measured by CHART Questionnaire.

    90 days

    Thinking and memoryWalking and mobility
  • Depressive Symptom Severity

    90 days

    Mood and sleep
  • Fatigue Symptoms

    90 days

    Fatigue
  • Epworth Sleepiness Scale

    90 days

    Mood and sleep

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Adult patients with chronic SCI/D (>3 months post injury) * American Spinal Injury Association (ASIA) classification A-D (i.e., excluding those with no evidence of a neurologic deficit based on ASIA classification).

Exclusion criteria

* Patients receiving mechanical ventilation * already using PAP for SDB at optimal compliance * A clinical contraindication that prevents PAP use. * recent health event that may affect sleep, e.g.: * CVA * acute MI * recent surgery or hospitalization * alcohol or substance abuse (\<90 days sobriety) * self-described as too ill to engage in study procedures * unable to provide self-consent for participation (e.g., due to dementia) * the investigators will offer to re-contact patients 90 days after a health event or after 90 days of sobriety

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Sleep-disordered breathing (SDB) remains under-treated in individuals living with spinal cord injuries and disorders (SCI/D). The investigators' aim is to test a program that addresses challenges and barriers to positive airway pressure (PAP) treatment of SDB among patients with SCI/D. The investigators anticipate that patients who receive this program will have higher rates of PAP use and will demonstrate improvements in sleep quality, general functioning, respiratory functioning and quality of life from baseline to 6 months follow up compared to individuals who receive a control program. This work addresses critical healthcare needs for patients with SCI/D and may lead to improved health and quality of life for these patients.

Papers

Loading reviews and guidelines…

History

    1. Started

      May 2017

    2. Main results due

      Sept 2019

    3. Finished

      Mar 2020

    4. Results posted

      Apr 2021

    Assembled by software from public sources.